Daniel L. Boeglin
Plus aucun poste en cours
Profil
Daniel L.
Boeglin worked as a Director & Legal Counsel at CoLucid Pharmaceuticals, Inc., Secretary at Endocyte, Inc., and Principal at Faegre Baker Daniels LLP.
He received an undergraduate degree from Kelley School of Business in 1982 and a graduate degree from the University of Virginia School of Law in 1985.
Anciens postes connus de Daniel L. Boeglin
| Sociétés | Poste | Fin |
|---|---|---|
| COLUCID PHARMACEUTICALS INC | Director/Board Member | 13/01/2014 |
Faegre Baker Daniels LLP
 Faegre Baker Daniels LLP Miscellaneous Commercial ServicesCommercial Services Faegre Baker Daniels LLP provides legal services. The firm serves business and corporate services, environmental law, finance and restructuring, government services, intellectual property, litigation and advocacy, real estate and construction, and wealth management. The company was founded in 1863 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
| ENDOCYTE, INC. | Corporate Secretary | - |
Formation de Daniel L. Boeglin
| Kelley School of Business | Undergraduate Degree |
| University of Virginia School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
CoLucid Pharmaceuticals, Inc.
 CoLucid Pharmaceuticals, Inc. BiotechnologyHealth Technology CoLucid Pharmaceuticals, Inc. engaged in the development of therapeutics for neurological disorders. Its products included Lasmiditan, a neurally acting anti-migraine agent that is designed to delivered efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease and psychiatric disorders. The company was founded by James F. White and Arthur M. Pappas in 2005 and was headquartered in Cambridge, MA. | Health Technology |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Faegre Baker Daniels LLP
Faegre Baker Daniels LLP Miscellaneous Commercial ServicesCommercial Services Faegre Baker Daniels LLP provides legal services. The firm serves business and corporate services, environmental law, finance and restructuring, government services, intellectual property, litigation and advocacy, real estate and construction, and wealth management. The company was founded in 1863 and is headquartered in Minneapolis, MN. | Commercial Services |
